Astec LifeSciences Q4FY2022 consolidated PAT surges to Rs. 43.05 crores

Astec LifeSciences Limited has reported Consolidated financial results for the period ended March 31, 2022.

Financial Results (Q4 FY2022) - QoQ Comparison

The company has reported total income of Rs. 278.7868 crores during the period ended March 31, 2022 as compared to Rs. 175.3130 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs. 43.0546 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 24.7468 crores for the period ended December 31, 2021.

The company has reported EPS of Rs. 21.96 for the period ended March 31, 2022 as compared to Rs. 12.62 for the period ended December 31, 2021.

Financials	Q4 FY2022	Q3 FY2022	% Change
Total Income	₹ 278.7868 crs	₹175.3130 crs	59.02%
Net Profit	₹43.0546 crs	₹24.7468 crs	73.98%
EPS	₹21.96	₹12.62	74.01%

Financial Results (Q4 FY2022) - YoY Comparison

The company has reported total income of Rs. 278.7868 crores during the period ended March 31, 2022 as compared to Rs.173.4696 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.43.0546 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.23.9596 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.21.96 for the period ended March 31, 2022 as compared to Rs.12.23 for the period ended March 31, 2021.

Financials	Q4 FY2022	Q4 FY2021	% Change
Total Income	₹ 278.7868 crs	₹173.4696 crs	60.71%
Net Profit	₹43.0546 crs	₹23.9596 crs	79.70%
EPS	₹21.96	₹12.23	79.56%

Financial Results (Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.687.0339 crores during the Financial Year ended March 31, 2022 as compared to Rs.562.7932 crores during the Financial Year ended March 31, 2021.

The company has posted net profit / (loss) of Rs.89.8586 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.65.0489 crores for the Financial Year ended March 31, 2021.

The company has reported EPS of Rs.45.85 for the Financial Year ended March 31, 2022 as compared to Rs.33.21 for the Financial Year ended March 31, 2021.

Financials	Year Ended FY2022	Year Ended FY2021	% Change
Total Income	₹687.0339 crs	₹562.7932 crs	22.08%
Net Profit	₹89.8586 crs	₹65.0489 crs	38.14%
EPS	₹45.85	₹33.21	38.06%

Asset Quality:

Asset Quality	Q4 FY2022	Q3 FY2022	Q4 FY2021
Gross NPA	₹ crs	₹ crs	₹ crs
Gross NPA %	%	%	%
Net NPA	₹ crs	₹ crs	₹ crs
Net NPA %	%	%	%

Gross NPA was at ₹ crs in Q4 FY2022 against ₹ crs in Q4 FY2021. The same was at ₹ crs in Q3 FY2022.

Net NPA was at ₹ crs in Q4 FY2022 against ₹ crs in Q4 FY2021. The same was at ₹ crs in Q3 FY2022.

GNPA was at % of Gross advances as on March 31, 2022 as compared to % as on March 31, 2021 and % as of December 31, 2021.

Net NPA was at % of Gross advances as on March 31, 2022 as compared to % as on March 31, 2021 and % as of December 31, 2021.

Ratios	Q4 FY2022	Q3 FY2022	Q4 FY2021
RoA %	%	%	%
CAR (BASEL III) %	%	%	%

Return on Average Assets (RoA) is at % for Q4 FY2022 against % in Q3 FY2022 and % in Q4 FY2021.

In Q4 FY2022, Bank's total Capital Adequacy Ratio (CAR) was at %, as compared to % in Q3 FY2022 and % in Q4 FY2021.

Shares of Astec LifeSciences Limited was last trading in BSE at Rs. 1941.90 as compared to the previous close of Rs. 1829.95. The total number of shares traded during the day was 9324 in over 2458 trades.

The stock hit an intraday high of Rs. 1988.65 and intraday low of 1814.70. The net turnover during the day was Rs. 18010609.00.

Source : Equity Bulls

Keywords

AstecLifeSciences Q4FY22 FY2022 ResultUpdate